发明名称 THERAPEUTIC 1,2,3,6-TETRAHYDROPYRIMIDINE-2-ONE COMPOSITIONS AND METHODS THEREWITH
摘要 A therapeutic composition is provided that comprises a 1-R1-phenyl, 4-R2- phenyl substituted 1,2,3,6-tetrahydropyrimidine-2-one cold receptor agonist in a therapeutically effective amount. The composition preferably further comprises one or more pharmaceutically active drugs such as an anti- inflammatory glucocorticosteroid, a sympathomimetic amine decongestant, an antihistamine, a local anesthetic, menthol or a menthol analog, an immunosuppressant, and mixtures thereof. The cold receptor agonist may be represented by the general formula (1)-[R1-phenyl]-4-[R2-phenyl]-1,2,3,6- tetrahydropyrimidine-2-one wherein: R1 is -hydroxy, -chloro, - fluoro, -alky l, -acetoxy, -trifluoromethyl ; and R2 is -nitro, -chloro, -fluoro, -alkyl, - trifluoromethyl. Therapeutic compositions of the invention elicit long-lasti ng cooling or soothing, particularly when formulated for delivery to suppress t he sensations of itch and pain, such as for delivery to inflamed skin, to the mucous membranes of the eyelids, of the anogenital areas and of the airways, and to the enteric mucosa.
申请公布号 CA2483090(A1) 申请公布日期 2003.11.13
申请号 CA20032483090 申请日期 2003.04.28
申请人 CRAGMONT PHARMACEUTICALS, LLC 发明人 WEI, EDWARD T.
分类号 C07D239/22;A61J1/03;A61K9/00;A61K9/02;A61K9/107;A61K9/70;A61K9/72;A61K31/513;A61K31/56;A61K45/00;A61M15/08;A61M35/00;A61P17/02;A61P17/04;A61P29/00;(IPC1-7):A61K31/513 主分类号 C07D239/22
代理机构 代理人
主权项
地址